Comparing Gly11/dAla11-Replacement vs. The In-Situ Neprilysin-Inhibition Approach on the Tumor-Targeting Efficacy of the 111In-Sb3/111In-Sb4 Radiotracer Pair
Molecules - Switzerland
doi 10.3390/molecules24061015
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 13, 2019
Authors
Publisher
MDPI AG